NATURE COMMUNICATIONS Momozawa, Y, Dmitrieva, J, Théâtre, E, Deffontaine, V, Rahmouni, S, Charloteaux, B, Crins, F, Docampo, E, Elansary, M, Gori, A-S, Lecut, C, Mariman, R, Mni, M, Oury, C, Altukhov, I, Alexeev, D, Aulchenko, Y, Amininejad, L, Bouma, G, Hoentjen, F, Löwenberg, M, Oldenburg, B, Pierik, M J, Vander Meulen-de Jong, A E, Janneke van der Woude, C, Visschedijk, M C, Lathrop, M, Hugot, J-P, Weersma, R K, De Vos, M, Franchimont, D, Vermeire, S, Kubo, M & Louis, E & Georges, M 2018, ' IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes ', Nature Communications, vol. 9, no. 1, pp. 2427 . https://doi.org/10.1038/s41467-018-04365-8 Nature Communications Nature Communications, 9:2427. Nature Publishing Group Nature communications, Vol. 9, no. 1, p. 2427 (2018)
Sandborn, W J, Feagan, B G, Rutgeerts, P, Hanauer, S, Colombel, J-F, Sands, B E, Lukas, M, Fedorak, R N, Lee, S, Bressler, B, Fox, I, Rosario, M, Sankoh, S, Xu, J, Stephens, K, Milch, C, Parikh, A, GEMINI 2 Study Group & Andersen, V 2013, ' Vedolizumab as induction and maintenance therapy for Crohn's disease ', The New England Journal of Medicine, vol. 369, no. 8, pp. 711-721 . https://doi.org/10.1056/NEJMoa1215739 New England Journal of Medicine, vol. 369, no. 8, pp. 711-721 New England Journal of Medicine, 369(8), 711-721. Massachussetts Medical Society
Cleynen, I, Boucher, G, Jostins, L, Schumm, L P, Zeissig, S, Ahmad, T, Andersen, V, Andrews, J M, Annese, V, Brand, S, Brant, S R, Cho, J H, Daly, M J, Dubinsky, M, Duerr, R H, Ferguson, L R, Franke, A, Gearry, R B, Goyette, P, Hakonarson, H, Halfvarson, J, Hov, J R, Huang, H, Kennedy, N A, Kupcinskas, L, Lawrance, I C, Lee, J C, Satsangi, J, Schreiber, S, Théâtre, E, van der Meulen-de Jong, A E, Weersma, R K, Wilson, D C, Parkes, M, Vermeire, S, Rioux, J D, Mansfield, J, Silverberg, M S, Radford-Smith, G, McGovern, D P B, Barrett, J C, Lees, C W & International Inflammatory Bowel Disease Genetics Consortium 2016, ' Inherited determinants of Crohn's disease and ulcerative colitis phenotypes : a genetic association study ', The Lancet, vol. 387, no. 10014, pp. 156-167 . https://doi.org/10.1016/S0140-6736(15)00465-1 LANCET Lancet, 387(10014), 156-167 Lancet (London, England) Cleynen, I, Boucher, G, Jostins, L, Schumm, L P, Zeissig, S, Ahmad, T, Andersen, V, Andrews, J M, Annese, V, Brand, S, Brant, S R, Cho, J H, Daly, M J, Dubinsky, M, Duerr, R H, Ferguson, L R, Franke, A, Gearry, R B, Goyette, P, Hakonarson, H, Halfvarson, J, Hov, J R, Huang, H, Kennedy, N A, Kupcinskas, L, Lawrance, I C, Lee, J C, Satsangi, J, Schreiber, S, Théâtre, E, van der Meulen-de Jong, A E, Weersma, R K, Wilson, D C, Parkes, M, Vermeire, S, Rioux, J D, Mansfield, J, Silverberg, M S, Radford-Smith, G, McGovern, D P B & Barrett, J C & Lees, C W 2016, ' Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study ', The Lancet, vol. 387, no. 10014, pp. 156-167 . https://doi.org/10.1016/S0140-6736(15)00465-1 Lancet (London, England), Vol. 387, no. 10014, p. 156-67 (2016) The Lancet, 387(10014), 156-167. ELSEVIER SCIENCE INC